Sibusiso Maseko
Sibusiso Maseko
University of Liege,GIGA-Signal Transduction Unit
Verified email at
Cited by
Cited by
A proteome-scale map of the SARS-CoV-2–human contactome
DK Kim, B Weller, CW Lin, D Sheykhkarimli, JJ Knapp, G Dugied, ...
Nature Biotechnology 41 (1), 140-149, 2023
Purification and characterization of naturally occurring HIV-1 (South African subtype C) protease mutants from inclusion bodies
SB Maseko, S Natarajan, V Sharma, N Bhattacharyya, T Govender, ...
Protein expression and purification 122, 90-96, 2016
The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
C Vandermeulen, T O’grady, J Wayet, B Galvan, S Maseko, M Cherkaoui, ...
PLoS pathogens 17 (9), e1009919, 2021
Purification and Characterization of Exo-Inulinase from Paenibacillus sp. d9 Strain
S Jeza, SB Maseko, J Lin
The protein journal 37, 70-81, 2018
I36T↑ T mutation in South African subtype C (C-SA) HIV-1 protease significantly alters protease-drug interactions
SB Maseko, E Padayachee, T Govender, Y Sayed, G Kruger, ...
Biological chemistry 398 (10), 1109-1117, 2017
Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics …
VT Sabe, GF Tolufashe, CU Ibeji, SB Maseko, T Govender, GEM Maguire, ...
Journal of Molecular Modeling 25, 1-16, 2019
Investigation of the binding free energies of FDA approved drugs against subtype B and C-SA HIV PR: ONIOM approach
ZK Sanusi, T Govender, GEM Maguire, SB Maseko, J Lin, HG Kruger, ...
Journal of Molecular Graphics and Modelling 76, 77-85, 2017
An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑ N↑ L PR mutant
ZK Sanusi, T Govender, GEM Maguire, SB Maseko, J Lin, HG Kruger, ...
Journal of Computer-Aided Molecular Design 32, 459-471, 2018
Purification and characterization of α-amylase from Paenibacillus sp. D9 and Escherichia coli recombinants
K Naidu, S Maseko, G Kruger, J Lin
Biocatalysis and Biotransformation 38 (1), 24-34, 2020
Optimized procedure for recovering HIV-1 protease (C-SA) from inclusion bodies
SB Maseko, D Govender, T Govender, T Naicker, J Lin, GEM Maguire, ...
The protein journal 38, 30-36, 2019
A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals
J Olivet, SB Maseko, AN Volkov, K Salehi-Ashtiani, K Das, ...
Molecular Therapy 30 (5), 1797-1800, 2022
Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D up arrow G up arrow S mutant in the South African HIV-1 subtype C protease
S Maseko, E Padayachee, S Maphumulo, T Govender, Y Sayed, ...
Mechanistic insight on the inhibition of D, D-carboxypeptidase from Mycobacterium tuberculosis by β-lactam antibiotics: an ONIOM acylation study
T Ntombela, A Seupersad, S Maseko, CU Ibeji, G Tolufashe, ...
Journal of Biomolecular Structure and Dynamics 40 (17), 7645-7655, 2022
Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA‐approved inhibitors: MD study
SI Maphumulo, AK Halder, T Govender, S Maseko, GEM Maguire, ...
Chemical biology & drug design 92 (5), 1899-1913, 2018
AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor
P Trepte, C Secker, J Olivet, J Blavier, S Kostova, SB Maseko, I Minia, ...
Molecular Systems Biology 20 (4), 428-457, 2024
Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction
SB Maseko, Y Brammerloo, I Van Molle, A Sogues, C Martin, C Gorgulla, ...
Antiviral research 217, 105675, 2023
Nanobodies against SARS-CoV-2 non-structural protein Nsp9 inhibit viral replication by targeting innate immunity
T Venit, J Blavier, SB Maseko, S Shu, L Espada, C Breunig, HP Holthoff, ...
bioRxiv, 2023.10. 12.561992, 2023
Interactome and structural basis for targeting the human T-cell leukemia virus Tax oncoprotein
SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, ...
bioRxiv, 2021.08. 25.457680, 2021
A gut meta-interactome map reveals modulation of human immunity by microbiome effectors
V Young, B Dohai, TCA Hitch, P Hyden, B Weller, NS Heusden, D Saha, ...
bioRxiv, 2023.09. 25.559292, 2023
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor (preprint)
P Trepte, C Secker, S Kostova, SB Maseko, SG Choi, J Blavier, I Minia, ...
The system can't perform the operation now. Try again later.
Articles 1–20